Abstract

A serological survey for the detection of antibodies to Mycoplasma bovis was conducted in Adamawa State, Nigeria during the year 2012. A total of 400 serum samples were collected from three local government areas (LGA) namely Yola (n=140), Mubi (n=130) and Ganye (n=130), and the samples were examined for the presence of M. bovis antibodies using BIO-X M. bovis antibody ELISA Kit. The overall seroprevalence of M. bovis was recorded as 19.5% (n=78/400). The highest seroprevalence was recorded in Ganye LGA (27.7%; n=36/130), followed by Yola LGA (20.0%; n=28/140) and Mubi LGA (10.8%; n=14/130). The cattle aging

Highlights

  • Mycoplasma bovis is a common inhabitant of the upper and lower respiratory tracts of healthy and pneumonic cattle (Thomas et al, 2002)

  • M. bovis is considered as a significant cause of several diseases like mastitis (Byrne et al, 2000), arthritis (Stipkovits et al, 1993), genital disorders and abortion (Byrne et al, 1999), bovine pneumonia (Pfützner and Sachse, 1996), and reduction of in vitro fertility (Eaglesome and Garcia, 1990)

  • The highest seroprevalence was recorded in Ganye (27.7%), followed by Yola (20.0%) and Mubi (10.8%) local government areas (LGA), these showed a statistical significant difference (p=0.003; p

Read more

Summary

Introduction

Mycoplasma bovis is a common inhabitant of the upper and lower respiratory tracts of healthy and pneumonic cattle (Thomas et al, 2002). M. bovis is a significant but sometimes neglected bacterial pathogen of adult dairy cattle, intensively reared beef, and dairy calves (Maunsell et al, 2011; Rérat et al, 2012). M. bovis is considered as a significant cause of several diseases like mastitis (Byrne et al, 2000), arthritis (Stipkovits et al, 1993), genital disorders and abortion (Byrne et al, 1999), bovine pneumonia (Pfützner and Sachse, 1996), and reduction of in vitro fertility (Eaglesome and Garcia, 1990). Mycoplasmas cause several economically costly diseases in cattle. 157,000 calves die each year due to pneumonia and related diseases, which have a approximate market value of about €99 million (Vanden-Bush and Rosenbusch, 2003). M. bovis may be responsible for at least one quarter to a third of these losses, this may be underestimated (Nicholas et al, 2000)

Objectives
Methods
Results
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.